Discovery of novel 3-Benzyloxyaminopyridines as orally available and intracranially active selective ROS1 inhibitors for combating the resistant ROS1G2032R mutation
用户6X7Ch8WUQ_gI
1个月前
65
10
已完结
1. 系统已在2025-09-05 17:11:19对应助文件进行删除
2. 如有需要请重新发布求助信息
注: 所有应助的资源仅供学习交流使用, 不得违反相关法律法规
DOI: https://doi.org/10.1016/j.ejmech.2025.118089
文献链接: https://linkinghub.elsevier.com/retrieve/pii/S0223523425008542
其他信息:
出版社: Elsevier BV
作者: Siming Liu; Yuanxin Tian; Yaqi Huang; Yong Lin; Guowu Wu; Zichao Yang; Fengqiu Guo; Yongxin Chen; Chunhui Huang; Ying Jiang; Chuan Huang; Zhonghuang Li; Shanhe Wan; Xiaoyun Wu; Jiajie Zhang
